Black chokeberry (aronia) and heart and metabolic health

What 2 graded rows on black chokeberry (aronia) agree on for heart and metabolic health, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Black chokeberry (aronia) page, with its PubMed record.

Your question

Supplement
Black chokeberry (aronia) Choose another

Black chokeberry (aronia) and heart and metabolic health

2 rows · 710 people

Split. 1 row found an improvement and 1 found no difference.

No difference
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade D× 1
  • No effect× 1
Rows
2
Trials
11
People
710
Pooled reviews may count some twice

Where they differ

From the rows
Trial sizeStudy designHow longWho was studiedWhen published

The best-graded row, grade D, is a randomized trial of 44 people (2026) and found an improvement. 1 row is graded No effect, our grade for adequately powered trials that found no effect.

The row that found no difference was larger: 666 people, against 44 people for the row that found an improvement.

The row that found no difference is a pooled review of several trials; the row that found an improvement is a single study.

The row that found an improvement ran longer (8 weeks) than the row that found no difference (2 weeks).

Only the row that found an improvement names women, men and older adults in its population.

The row that found an improvement is newer (2026) than the row that found no difference (2025).

The rows

1 improved · 1 no difference
  1. Grade DMetabolic syndrome markers in older adults · Improved

    RCT · n 44 · 2026 · Older adults with metabolic syndrome (12 men, 32 women)

    10 g/day · 8 weeks

    Versus control, diastolic pressure fell 10 mmHg, triglycerides 9.0 mg/dL and LDL cholesterol 6.3 mg/dL, with lower TNF-α, IL-6 and oxidised LDL; weight and other body measurements did not change.

    Row on the Black chokeberry (aronia) page · PubMed 40905799 (opens PubMed)

  2. No effectCardiometabolic markers (body weight, glucose, lipids, blood pressure) · No difference

    Meta-analysis, 10 studies · n 666 · 2025 · Adults with or without cardiometabolic risk factors

    Varied across trials · 2 weeks or longer

    No significant effect on any cardiometabolic outcome overall. Subgroups suggested lower total and LDL cholesterol when baseline cholesterol was under 200 mg/dL and lower systolic pressure with more than 50 mg/day anthocyanins, while fasting glucose rose in people aged 50 or younger. Certainty of evidence was very low.

    Row on the Black chokeberry (aronia) page · PubMed 40362797 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.